Matrix metalloproteinase 9 inhibition reduces early brain injury in cortex after subarachnoid hemorrhage

Acta Neurochir Suppl. 2011;110(Pt 1):81-4. doi: 10.1007/978-3-7091-0353-1_15.

Abstract

This study investigated the role of matrix metalloproteinase-9 (MMP-9) in early brain injury (EBI) after subarachnoid hemorrhage (SAH). Sprague-Dawley male rats (n=30) between 250 and 300 g were used. SAH was produced by injecting autologous arterial blood into the prechiasmatic cistern. SB-3CT, a selective MMP-9 inhibitor, was injected intraperitoneally after SAH induction. MMP-9 protein expression was measured by western blot; laminin expression and neuronal cells in the cerebral cortex were studied by immunohistochemistry and TUNEL staining at 24h after SAH. MMP-9 expression was increased after SAH and decreased by SB-3CT inhibition at 24h after SAH (P<0.01). Laminin, the substrate of MMP-9, was decreased at 24h after SAH, and SB-3CT prevented laminin degradation. The number of TUNEL-positive neurons in cerebral cortex was increased after SAH and decreased by SB-3CT (P<0.01). MMP-9 may be involved in EBI after SAH and inhibition of MMP-9 may reduce EBI in cerebral cortex.

MeSH terms

  • Analysis of Variance
  • Animals
  • Brain Injuries* / enzymology
  • Brain Injuries* / etiology
  • Brain Injuries* / pathology
  • Cerebral Cortex / drug effects
  • Cerebral Cortex / enzymology*
  • Cerebral Cortex / pathology
  • Disease Models, Animal
  • Down-Regulation / drug effects
  • Down-Regulation / physiology*
  • Enzyme Inhibitors / pharmacology
  • Heterocyclic Compounds, 1-Ring / pharmacology
  • In Situ Nick-End Labeling
  • Laminin / metabolism
  • Male
  • Matrix Metalloproteinase 9 / metabolism*
  • Neurons
  • Rats
  • Rats, Sprague-Dawley
  • Subarachnoid Hemorrhage / complications*
  • Sulfones / pharmacology

Substances

  • Enzyme Inhibitors
  • Heterocyclic Compounds, 1-Ring
  • Laminin
  • SB 3CT compound
  • Sulfones
  • Matrix Metalloproteinase 9